Heart to Heart Nurses: Recent Episodes
Preventive Cardiovascular Nurses Association
Heart to Heart Nurses is brought to you by the Preventive Cardiovascular Nurses Association. Each episode will provide you with knowledge and tools you can apply to the prevention and management of cardiovascular disease across the lifespan.
[CE contact hours--see below.]: Guest Cindy Lamendola, MSN, NP, FAHA, FPCNA, describes the impacts of elevated Lp(a) on the body. Current clinical trials, and the necessity of including diverse participants are described, as well as the importance of keeping Lp(a) front of mind no matter our role as healthcare professionals.
CE LINK: https://pcna.net/online-course/ce-podcast-were-all-responsible-for-lpa
Lipoprotein(a) and its Significance in Cardiovascular Disease: A Review: Duarte Lau F, et al. JAMA Cardiol. 2022. PMID: 35583875 Review
Lipoprotein(a) and LDL-C: The Relevance of Equivalence: Journal of the American College of Cardiology [0735-1097] Morris yr:2022 vol:80 iss:21 pg:2011 -2013
Equivalent Impact of Elevated Lp(a) and FH in Patients with ASCVD: https://www.jacc.org/doi/10.1016/j.jacc.2022.09.021
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
[CE contact hours--see below.] While Lp(a) levels are generally hereditary in nature, other factors can cause elevated levels. Learn about current guidelines-directed medical therapies, and how guests Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, and Kathy Byrne, MSN, CRNP, CCRN. apply these guidelines into clinical practice.
CE LINK: https://pcna.net/online-course/ce-podcast-lurking-lpa-hiding-just-below-the-surface
2018 AHA/ACC multi-society guidelines: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000625
ODYSSEY outcome study: https://www.nejm.org/doi/full/10.1056/nejmoa1801174
FOURIER study: https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2017/03/16/00/46/FOURIER
AIM-HIGH study: https://www.nejm.org/doi/full/10.1056/nejmoa1107579
HPS2-THRIVE study:https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2014/07/15/14/43/HPS2-THRIVE
ESPRIT trial: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201299/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
[CE contact hours--see below.] : Guests Kathy Byrne, MSN, CRNP, CCRN.,and Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, describe the most common genetic dyslipidemia--elevated lipoprotein (a), or Lp(a). The discussion includes testing for Lp(a)--especially for family members, and others who may be at risk. Resources for patients and HCPs are also part of the conversation.
CE LINK:https://pcna.net/online-course/ce-podcast-lpa-closer-to-home-than-you-think
PCNA Lp(a) patient education sheet: https://pcna.net/clinical-resources/patient-handouts/lipoproteina-patient-tools-and-handouts/
National Lipid Association: https://www.lipid.org/
Family Heart Foundation: https://familyheart.org/
European Atherosclerosis Society Lp(a) Consensus Statement: https://eas-society.org/page/lipoproteina-consensus-2022/
2018 AHA/ACC multi-society guidelines: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000625
American Heart Association: https://www.heart.org/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Only 20% of patients with atrial fibrillation are symptomatic for all their AFib episodes. Guest Dan Sorajja, MD, FACC, FHRS describes AFib diagnosis and patient-based treatment decisions for AFib. Dr. Sorajja also discusses Long QT Syndrome and team-based care.
PCNA AFib patient tools: https://pcna.net/clinical-resources/patient-handouts/atrial-fibrillation-tools-and-handouts/
PCNA HCP tools (including pocket guide and screening resources): https://pcna.net/clinical-resources/provider-tools/atrial-fibrillation-provider-tools/
CE Course: Stroke Prevention Through AFib Recognition & Treatment: https://pcna.net/online-course/start-stroke-prevention-through-afib-recognition-and-treatment/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Applying guidelines-directed therapies for antiplatelets and antithrombotics requires balancing the risks of cardiovascular events and the risk of bleeding. Guest Erin Michos, MD, MHS, FACC, FAHA, FASE, FASCP, describes the use shared decision-making with patients who are at higher risk for thrombotic events, and discusses pharmacotherapies recommended for use with particular patient groups.
2019 AHA/ACC Primary Prevention Guidelines: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000678
US Preventive Service Task Force 2022 Aspirin Recommendations: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication
CURE Trial 2022: https://www.ahajournals.org/doi/10.1161/01.cir.0000029926.71825.e2
DAPT risk calculator: https://tools.acc.org/daptriskapp/#!/content/calculator/
PRECISE-DAPT score: http://www.precisedaptscore.com/predapt/
TWILIGHT trial: https://www.nejm.org/doi/full/10.1056/NEJMoa1908419
2021 AHA/ACC/SCAI guidelines for acute coronary disease: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001038
COMPASS trial: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.046048
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
An estimated 8.5 million adults over the age of 40 have PAD, yet up to half have no symptoms. Guest Lola Coke, PhD, ACNS-BC, FAHA, FPCNA, FAAN, describes how the disease disproportionately impacts individuals who are Black, Latinx, and Native American, and how clinician awareness can make a positive difference in effective diagnosis and management.
PAD Patient education tools (PCNA): https://pcna.net/clinical-resources/patient-handouts/peripheral-artery-disease-tools-and-handouts/
PAD Screening Toolkit, Activity Program: https://pcna.net/clinical-resources/provider-tools/peripheral-artery-disease-provider-tools/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Hypertrophic Cardiomyopathy (HCM) is the most common genetic heart condition. Typical symptoms, testing, and treatment options are discussed, as well as the role of genetic counseling and referrals to a Center of Excellence in HCM team-based care. Guest: Heidi Salisbury, RN, MSN, CNS-BC, ACGN.
Hypertrophic Cardiomyopathy Association: https://4hcm.org/
HCM Centers of Excellence: https://4hcm.org/center-of-excellence/
PCNA HCM patient education: https://pcna.net/clinical-resources/patient-handouts/hypertrophic-cardiomyopathy-patient-tool/
PNCA HCP resources: https://pcna.net/clinical-resources/provider-tools/hypertrophic-cardiomyopathy-provider-tools/
PCNA CE Course: HCM in Clinical Practice: https://pcna.net/online-course/hypertrophic-cardiomyopathy-hcm-in-clinical-practice/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
The assessment and treatment of chest pain--both acute and chronic--is the focus of this conversation with guest Debabrata Mukherjee, MD. Dr. Mukherjee describes risk stratification, appropriate testing, and shared decision-making with patients with chest pain, as well as the importance of preventive care.
The HEART score: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005932/
2021 Chest Pain Guidelines: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001029
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Stephanie Little, MSN, RNC-OB, C-EFM, examines cardio-obstetrics, a growing field focused on the link of CVD in patients who are pregnant, post-partum, or have had pregnancy-related health issues. The conversation also includes information about professional development throughout the nursing career, and a review of the importance of nutrition on heart health.
PCNA CE Course: https://pcna.net/online-course/reducing-maternal-mortality-through-comprehensive-antenatal-and-postnatal-cardiovascular-care/
PCNA online courses: https://pcna.net/professional-development/online-learning/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In the final of this three-part content series join colleagues Amy Chybowski, NP and Jonathan Milton, MA, BSN, RN, CCRN-CMC as they discuss the different treatment pathways for patients with pulmonary hypertension (PH). Learn about the three different treatment options and the important role of team-based care.
Pulmonary Hypertension Association Patient Resources
https://phassociation.org/patients/resources/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In this second episode of a three-part content series on pulmonary hypertension (PH) we sit down with Raza Farhan, MD and discuss the diagnosis journey of PH. Dr. Raza describes the nuiances behind PH WHO gropus and dives into right heart catherizations.
Performance and Interpretation of Invasive Hemodynamic Exercise Testing
https://www.sciencedirect.com/science/article/abs/pii/S0012369220316172?casa_token=iATn9dmahAoAAAAA:xYsWsL7K7b2TSaYn6ecXbe9fwm1hcdvIDLD7gLEj51KGB98GXgfUyI7GP7NAxD_fgDUJLvdf
Distinguishing exercise intolerance in early‐stage pulmonary hypertension with invasive exercise hemodynamics: Rest V E/VCO2 and ETCO2 identify pulmonary vascular disease
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286332/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Hear from guests Traci Housten, RN, MS and Lisa Maher, DNP, ARNP, FNP-BC, FPCNA in the first episode of this three-part content series on pulmonary hypertension (PH). Traci and Lisa discuss the complexity around recognizing PH from both the general cardiology and speciality clinician standpoint and dive into what providers should be on the lookout for and which tests can be ordered. They also discuss how family history can play a role, the incidence of pulmonary hypertension, and the impact of a delayed diagnosis.
Plumonary Hypertension Association
www.phassociation.org
Galiè N, Channick RN, Frantz RP, Grünig E, Jing ZC, Moiseeva O, Preston IR, Pulido T, Safdar Z, Tamura Y, McLaughlin VV. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019 Jan 24;53(1):1801889. doi: 10.1183/13993003.01889-2018. PMID: 30545971; PMCID: PMC6351343.
Hoeper MM, Ghofrani HA, Grünig E, Klose H, Olschewski H, Rosenkranz S. Pulmonary Hypertension. Dtsch Arztebl Int. 2017;114(5):73-84. doi:10.3238/arztebl.2017.0073
Lung Association Pulmonary Hypertension Facts
https://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-arterial-hypertension/learn-about-pulmonary-arterial-hypertension#:~:text=PAH%20is%20most%20common%20in,each%20year%20in%20the%20U.S.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Hear from Kim Newlin, MSN, ANP, FPCNA, about some of the newest Heart Failure medications and guidelines. She will also discuss conversations with patients that should occur early in their diagnosis, and cardiac rehabilitation programs for these patients.
PCNA HF Patient Tools:https://pcna.net/clinical-resources/patient-handouts/heart-failure-tools-and-handout/
PCNA HF Tools for HCPs: https://pcna.net/clinical-resources/provider-tools/heart-failure-provider-tools/
DAPA-HF Trial: https://www.nejm.org/doi/full/10.1056/NEJMoa1911303
EMPEROR-Reduced trial: https://www.nejm.org/doi/full/10.1056/NEJMoa2107038
CE course "Heart Failure: Evidenced-based Pharmacologic Therapies"-Kimberly Cuomo, RN, MSN, CRNP, CHFN; part of 2022 Cardiovascular Nursing Symposium: https://pcna.net/online-course/2022-cardiovascular-nursing-symposium-pharmacology-sessions/
Million Hearts Cardiac Rehab Change Package: https://millionhearts.hhs.gov/tools-protocols/action-guides/cardiac-change-package/index.html
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Tune into a conversation between Cindy Bither, ACNP-BC, ANP representing the Preventive Cardiovascular Nurses Association (PCNA) and Ashlee Davis, BSMI, ACS, RDCS, FASE representing the American Society of Echocardiography (ASE) as they discuss the overall importance of echocardiography in diagnosing Cardiac Amyloidosis. Explore the team based perspectives from the speakers as they dive into when to order an echo, what to include in the echo order, and when to use Strain imaging.
PCNA Amyloid Podcasts: https://pcna.net/professional-development/heart-to-heart-podcast/
PCNA ASE Video: https://pcna.net/clinical-resources/provider-tools/attr-cm-provider-tools/
AAHFN Podcast: https://www.aahfn.org/page/Podcasts
AAHFN Manual: https://www.aahfn.org/store/viewproduct.aspx?id=16410228
ASE Cardiac Amyloidosis Resources: https://www.asecho.org/cardiacamyloidosis/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
LIsten to a conversation between Janell Grazzini Frantz, CNP, APRN, MSN, and Karen McClean, RN, as they discuss the needs of patietns with ATTR-CM. Explore the patient experience from the time of disease diagnosis, including the need for primary care management. Moderated by Kim Newlin, MSN, ANP, FPCNA.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Review resources for healthcare professionals and their patients with ATTR-CM, including written/electronic references, websites, mentors, organizations, support groups, clinical trials, and specialty clinics. Episode guests Janell Grazzine Frantz, CNP, APRN, MSN, and Johana Fajardo, DNP, ANP-BC, CHFN, FHFSA, with moderator Kim Newlin, MSN, ANP, FPCNA.
Heart Failure Society of America: https://hfsa.org/
Amyloidosis Support Groups: https://www.amyloidosissupport.org/
International Society of Amyloidosis https://www.isaamyloidosis.org/
American Society of Heart Failure Nurses https://www.aahfn.org/
A Guide for the Diagnosis and Management of Amyloidosis: https://www.aahfn.org/store/viewproduct.aspx?id=16410228
Mayo Clinic - amyloidosis: https://www.mayoclinic.org/diseases-conditions/amyloidosis/diagnosis-treatment/drc-20353183
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Learn about ATTR-CM symptoms and diagnostics, team-based care and specialists, and the importance of the nurse navigator role (even if that isn't your specific job title). Guests Janell Grazzini Frantz, CNP, APRN, MSN, and Linda Wick, MSN, CNP, CHFN, chat with moderator Kim Newlin, MSN, ANP, FPCNA.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Join Dr. Kathy Wood, PhD, RN, FAHA, FAAN, as she explores utilizing shared decision-making for your AFib patients. Leave this conversation with tools and resources to activate your patient's engagement in their AFib care.
Agency for Healthcare Research and Quality (AHRQ) website for Shared Decision Making (the SHARE mnemonic): https://www.ahrq.gov/health-literacy/professional-training/shared-decision/index.html
Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/484991
US hospital webpages on atrial fibrillation ablation: A potential source for misinformation: https://onlinelibrary.wiley.com/doi/abs/10.1111/jce.15606
Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE): https://pubmed.ncbi.nlm.nih.gov/26108807/
Provider Decision Aid Information:
Univ of CO Shared Decision Making website, Colorado Program for Patient Centered Decisions: https://patientdecisionaid.org/
Ottawa Hospital Research Institute: https://decisionaid.ohri.ca/AZlist.html).
Dartmouth Center for Shared Decision Making: https://www.dartmouth-hitchcock.org/shared-decision-making
ACC’s CardioSmart page on Shared Decision Making: https://www.cardiosmart.org/topics/decisions/shared-decisions
Health IT.gov Shared Decision Making tip sheet: https://www.healthit.gov/sites/default/files/nlc_shared_decision_making_fact_sheet.pdf
Patient Resources:
American Heart Association (AHA) sponsored website “My Afib Experience”: https://supportnetwork.heart.org/s/myafibmain
StopAFib.org patient site: https://www.stopafib.org/
Ongoing Trials:
ENHANCE AF: https://clinicaltrials.gov/ct2/show/NCT04096781
Univ of Colorado’ Patient Centered Decisions Research Group: https://patientdecisionaid.org/icd/atrial-fibrillation/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Atrial Fibrillation (AFib) and Venous Thromboembolism (VTE) have a risky bidirectional relationship. Hear from Carol Patrick, RNFA, ACNP-BC, FPCNA, as she explores this relationship and the different management and prevention techniques. Learn also about how cancer can increase a patient's risk for AFib and VTE.
PCNA AFib Resources: https://pcna.net/clinical-resources/provider-tools/atrial-fibrillation-provider-tools/
PCNA VTE Resources: https://pcna.net/clinical-resources/patient-handouts/vte-and-blood-clot-tools-and-handouts/
Atherosclerosis Risk in Community (ARIC) Study: https://onlinelibrary.wiley.com/doi/10.1111/jth.13974
Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review: https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0036-1598005
Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients: https://www.frontiersin.org/articles/10.3389/fcvm.2021.775564/full
American College of Cardiology, Atrial Fibrillation: Guideline For the Management of Patients: https://www.acc.org/guidelines/hubs/atrial-fibrillation
American College of Chest Physicians (CHEST): https://www.chestnet.org/
Anticoagulation FORUM, DOAC Playbook: https://acforum-excellence.org/Resource-Center/downloads/DOAC%20Playbook%20_07-2021.pdf
National Blood Clot Alliance: stoptheclot.org
National Heart, Lung, and Blood Institute (NHLBI): https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-heart-lung-blood-institute-nhlbi
World Thrombosis Day (WTD): https://www.worldthrombosisday.org/about/wtd/
Atrial fibrillation and cancer – An unexplored field in cardiovascular oncology: https://www.sciencedirect.com/science/article/abs/pii/S0268960X18301012?via%3Dihub
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Atrial Fibrillation (AFib) in conjunction with Heart Failure (HF) can be a fatal combination. Join Dr. Laura VanBrocklin, DNP, FNP, RN-BC, FPCNA, as she explores these co-morbidities and complicated care plans.
PCNA AFib Resources: https://pcna.net/clinical-resources/provider-tools/atrial-fibrillation-provider-tools/
PCNA HF Resources: https://pcna.net/clinical-resources/provider-tools/heart-failure-provider-tools/
ACC CardioSmart Resources: https://www.cardiosmart.org/topics/atrial-fibrillation
Heart Rhythm Society webpage: https://www.hrsonline.org/
American Association of Heart Failure Nurses, Heart Failure Prevention Resources: https://www.aahfn.org/page/HFPrevention
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Join Nancy Houston Miller, RN, BSN, FAHA, FPCNA, as she discusses the process of health behavior change and resources that can assist you and your patients. Whether the topic is diet, exercise, smoking, medication adherence or other behaviors, partnering with your patients is a key to success.
PCNA Behavior Change mini-certificate(CE course): https://pcna.net/online-course/behavior-change-mini-certificate/
Transtheoretical Model of Behavior Change (Prochaska, JO): https://psycnet.apa.org/record/1993-09955-001
Social Learning Theory (Bandura): Bandura A. Social Learning Theory. Englewood Cliffs, NJ: Prentice-Hall; 1977.
Steve Rollnick: https://www.stephenrollnick.com/
William Miller: https://williamrmiller.net/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
[CE contact hours--see below.] Improving quality of life for patients with heart failure can include lifestyle modifications and require successful behavior change strategies. Learn best practices to apply into your clinical setting from nurse providers Colleen McIlvennan, PhD, DNP, ANP, FAHA, FHFSA, of the University of Colorado in Denver, and Binu Koirala, PhD, MGS, RN, of the Johns Hopkins University School of Nursing in Baltimore.
CE LINK: https://pcna.net/?p=10717&post_type=online-course&preview_id=10717
PCNA Behavior Change mini-certifice (CE course): https://pcna.net/professional-development/online-learning/ "Behavior Change mini-certificate"
AHA HF Tools & Resources: heart.org/en/health-topics/heart-failure/heart-failure-tools-resources
Adherence to Healthy Sleep Patterns: ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.050792?url_ver=Z39.88-2003𝔯_id=ori%3Arid%3Acrossref.org𝔯_dat=cr_pub++0pubmed&
Addressing Social Determinants of Health in Patients with HF: ahajournals.org/doi/10.1161/CIR.0000000000000767
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
[CE contact hours--see below.] Health equity issues, including access ot medications, significantly impact patients with heart failure. From pharmacy deserts to non-medical switching and beyond, hear strategies to assist patients in getting the medications they need, from nurses Binu Koirala, PhD, MGS, RN, with the Johns Hopkins University School of Nursing in Baltimore, and Kim Newlin, MSN, ANP, FPCNA, of Sutter Roseville Medical Center in Northern California.
CE LINK: https://pcna.net/?p=10716&post_type=online-course&preview_id=10716
Access to Innovative Medicines Provider Tools: https://pcna.net/clinical-resources/provider-tools/access-for-innovative-medicines-provider-tools/
Medicare State Pharmaceutical Assistance Program: medicare.gov/pharmaceutical-assistance-program/#state-programs
Extra Help with Medicare Prescription Drug Care Costss: ssa.gov/benefits/medicare/prescriptionhelp.html
CoverMyMeds: covermymeds.com/main/
Solving Medication Access issues: acc.org/latest-in-cardiology/articles/2020/10/01/01/42/feature-advancing-health-equity-for-heart-failure-patients
Non-Medical Switching: cga.ct.gov/2017/rpt/2017-R-0008.htm#:~:text=%E2%80%9CNon%2Dmedical%20switching%E2%80%9D%20broadly,expensive%20but%20therapeutically%20equivalent%20drug
Health Equity: cdc.gov/chronicdisease/healthequity/index.htm
Understanding Copay Accumulators: https://infusioncenter.org/understanding-copay-accumulators-who-really-benefits/
PACH (Partnership to Advance Cardovascular Health): advancecardiohealth.org/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
[CE contact hours--see below.] Often prescribed for obesity, SGLT2is and GLP-1 RAs have a role in heart failure management. Learn about their mechanisms of action, and how their use extends beyond weight loss to cardioprotective and renalprotective properties. Guests: Kim Newlin, MSN, ANP, FPCNA, of Sutter Roseville Medical Center in Northern California, and Colleen McIlvennan, PhD, DNP, ANP, FAHA, FHFSA, from the University of Colorado in Denver.
CE Link: https://pcna.net/?p=10718&post_type=online-course&preview_id=10718
2022 AHA/ACC/HFSA 2022 Guideline for the Managment of HF: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063
Pocket Guide: Guidelines for Managing CVD Risk in Patients with Diabetes: https://pcna.net/clinical-resources/provider-tools/diabetes-provider-tools/
HF Pocket Guide: A Guide to Prevention and Management: https://pcna.net/clinical-resources/provider-tools/heart-failure-provider-tools/
New and Emerging Treatments for Heart Failure: HFrEF and HFpEF (CE course): https://pcna.net/online-course/new-and-emerging-treatments-for-heart-failure-hfref-and-hfpef/
SGLT2is in Heart Failure: ncbi.nlm.nih.gov/pmc/articles/PMC8654149/
SGLT2i in HFpEF: multicenter randomized trial: nature.com/articles/s41591-021-01536-x
Empagliflozin in HFpEF: https://www.nejm.org/doi/10.1056/NEJMoa2107038#:~:text=Empagliflozin%20in%20HF%20with%20Preserved%20Ejection%20Fraction&text=Sodium%E2%80%93glucose%20cotransporter%202%20(SGLT2,and%20a%20reduced%20ejection%20fraction.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Atrial fibrillation (AFib) management includes both pharmacologic and non-pharmacologic therapies.Guest Bill Miles, MD, FACC, of the University of Florida, Gainsville, describes how to effectively treat AFib--from asymptomatic younger patients without left ventricular dysfunction to older patients with significantly reduced ejection fraction.
AFib resources for patients
AFib resources for healthcare providers
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
The interrelationship of sleep apnea and atrial fibrillation (AFib) should be front of mind for clinicians. Learn keys to guideline-directed therapy including diagnosis, risk scores, the importance of anticoagulation, rate- and rhythm-controlling medications, and pacemakers, from guest Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, Unitypoint Health Allen Hospital Cardiovascular Center.
AFib resources for patients
AFib resources for healthcare providers
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Sexual and gender minorities--those identified as LGBQT+--are at increased risk of cardiovascular disease. Investigate the connections between heart health and minority stressors, poverty, care delays or avoidance, discrimination, and other factors affecting our patients, and how nurses can positively impact care and outcomes. Guest: Billy Cacaeres, PhD, RN, AGPCNC-BC, FAAN, of Columbia University.
Gay and Lesbian Medical Association glma.org
National LGBTQIA+ Education Center lgbtqiahealtheducation.org
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Cardiovascular disease prevention can--and should--begin before patients develop any risk factors. Learn about strategies for primoridial prevention (including maternal risks of CVD), reducing health disparities, and how they can be applied in clinical practice--no matter where patients are in their lifespan. Guest: Don Lloyd-Jones, President of the American Heart Association, and Chair of the Dept. of Preventive Medicine at Northwestern University.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Familial Hypercholesterol, the genetic condition that causes high LDL cholesterol levels, may lead to early heart attacks or heart disease If undiagnosed or untreated. Guest Susan Halli Demeter, DNP, CNP, NP, of the Mayo Clinic, describes diagnosis, heterozyogus and homozygous versions, treatments, and the importance of genetic screening for family members.
CE course The Role of Non-Statin Therapies in Optimal Cholesterol Management
Patient education What is Familial Hypercholesterolemia?
Patient & professional tools: Access to Innovative Medicines
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Developing and demonstrating leadership--regardless of your job title--helps improve patient outcomes, job satisfaction, and career advancement. Learn about the Future of Nursing repot, and how mentorship, training, and resources can help you in your career journey. Guest: Sandra B. Dunbar, RN, PhD, FAAN, FAHA, FPCNA, of Emory University.
Advancing the Cardiovascular Nursing Profession: https://pcna.net/advancing-the-cardiovascular-nursing-profession/
PCNA Leadership Series: https://pcna.net/event/leadership-series-leadership-in-the-workplace/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Cardio-oncology requires a team of individuals--primary care, oncology, cardiology, families, and caregivers--supporting the patient and the shared decision-making process. The COVID-19 pandemic effects on cardio-oncology are discussed, along with informational resources. Guests: Janet Celli, BSN, RN, PCCN, and Kerry Skurka, RN, BSN, F-ICOS.
Resources:
American College of Cardiology CardioSmart: cardiosmart.org
ICOS: ic-os.org
Cancer Support Community: cancersupportcommunity.org
Association of Community Cancer Centers: accc-cancer.org
Little Red Door: littlereddoor.org
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Patients with cancer are at increased risk of cardiovascular disease, months or years following their final cancer treatment--and the comorbidities for cancer and CVD overlap significantly. Guests Janet Celli, BSN, RN, PCCN, and Kerry Skurka, RN, BSN, F-ICOS, discuss risk reduction and the impact of health equity in these patients.
Resources:
American College of Cardiology CardioSmart: cardiosmart.org
ICOS: ic-os.org
Cancer Support Community: cancersupportcommunity.org
Association of Community Cancer Centers: accc-cancer.org
K Red Door: littlereddoor.org
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
A relatively new field, and a fast growing subspecialty, cardio-oncology addresses cardiovascular disease, or side effects, associated with cancer. Guests Janet Celli, BSN, RN, PCCN, and Kerry Skurka, RN, BSN, F-ICOS, discuss the clinical implications for patients who may experience cardiovascular disease during, or following, cancer treatment.
Resources:
American College of Cardiology CardioSmart: cardiosmart.org
ICOS: ic-os.org
Cancer Support Community: cancersupportcommunity.org
Association of Community Cancer Centers: accc-cancer.org
Little Red Door: littlereddoor.org
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In Hypertrophic Cardiomyopathy (HCM), left ventricle wall thickening reduces the heart's ability to pump blood efficiently. HCM treatment options are limited, and shared decision-making with patients, family members, and healthcare teammates is crucial throughout the disease journey. Guest: Deatrah Dubose, APN, of the Chanin T. Mast Center at Atlantic Health.
https://www.medscape.com/viewarticle/975122
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Hypertrophic Cardiomyopathy (HCM) diagnosis and management complicated; symptoms may include shortness of breath, severe arrhythmias, or inability to exercise. Rarely, very vigorous physical activity may trigger dangerous arrhythmias and even sudden cardiac arrest. Centers of Excellence provide best practice approaches to optimize patient outcomes. Guests include Heidi Salisbury, RN, MSN, CNS, from Stanford University, and Carol Patrick, RN, ACNP, from Northwell Health.
2020 AHA/ ACC Guidelines for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy , JACC, 76 (25), 2020.
https://www.jacc.org/doi/10.1016/j.jacc.2020.08.045
AHA Scientific Statement 12-step screening for SCD in High School Athletes 2016
HCM Centers of Excellence https://4hcm.org/center-of-excellence/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Hypertrophic Cardiomyopathy (HCM) is the most common genetic heart disease in the United States, with 1 in 500 (0.2%) diagnosed with the condition worldwide. Learn about the basics: signs, symptoms and diagnosis of HCM with guest Jane A. Linderbaum MS, ARNP, FACC, Associate Professor of Medicine at the Mayo Clinic.
Patient Education Resource: Hypertrophic Cardiomyopathy: What You Need to Know
https://pcna.net/clinical-resources/patient-handouts/hypertrophic-cardiomyopathy-patient-tool/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Cultural humility allows health care providers to effectively communicate by understanding the complexity of identies and experiences of our patients. Learn how cultural humility is defined, strategies for implementing it into practice to help improve interactions and patient outcomes, and health inequality factors that may impact our patients and their cardiovascular care. Guest Diana Baptise, DNP, RN, CNE, FPCNA, FAAN, is Assistant Professor – Center for Cardiovascular and Chronic Care at the Johns Hopkins School of Nursing.
PCNA Professional Development
https://pcna.net/professional-development/
PCNA Membership
https://pcna.net/member-center/
PCNA Event calendar
https://pcna.net/professional-development/event-calendar/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Cardiovascular Sequelae of COVID-19 in Adults includes myocaritis, long-COVID, and returning to play. Guest Ty Gluckman, MD, FACC, FAHA, co-chair of the related 2022 Expert Consensus Decision Pathway, shares clinical practices for ID and treatment of those with post-COVID sequelae, evaluating and managing patients who have--or have had--COVID-19, how CV symptoms may manifest weeks or months post-infection, the differences between PASC-CVD and PASC-CVS, and resources for you and your patients.
ACC expert consensus decision pathway:
https://www.jacc.org/doi/10.1016/j.jacc.2022.02.003
PCNA Membership
https://pcna.net/member-center/
PCNA Event calendar
https://pcna.net/professional-development/event-calendar/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.